83.21
前日終値:
$82.01
開ける:
$82.87
24時間の取引高:
4.34M
Relative Volume:
0.44
時価総額:
$106.51B
収益:
$36.36B
当期純損益:
$4.84B
株価収益率:
22.33
EPS:
3.7261
ネットキャッシュフロー:
$5.43B
1週間 パフォーマンス:
+0.01%
1か月 パフォーマンス:
+3.84%
6か月 パフォーマンス:
-17.52%
1年 パフォーマンス:
-9.87%
Medtronic Plc Stock (MDT) Company Profile
名前
Medtronic Plc
セクター
電話
01135314381700
住所
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
MDT
Medtronic Plc
|
83.21 | 104.98B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
ABT
Abbott Laboratories
|
103.06 | 175.49B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
330.25 | 122.28B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
44.25 | 64.78B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
82.63 | 48.26B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-13 | 再開されました | Barclays | Overweight |
| 2026-02-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-03 | 再開されました | Citigroup | Buy |
| 2026-01-30 | 再開されました | Wells Fargo | Overweight |
| 2026-01-06 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | アップグレード | Goldman | Sell → Neutral |
| 2025-06-30 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-03-04 | アップグレード | Citigroup | Neutral → Buy |
| 2024-10-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 繰り返されました | Oppenheimer | Perform |
| 2024-08-15 | アップグレード | UBS | Sell → Neutral |
| 2024-08-14 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | ダウングレード | UBS | Buy → Sell |
| 2023-01-09 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-11-23 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-11-16 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-08-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 開始されました | Wolfe Research | Underperform |
| 2022-06-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | ダウングレード | Needham | Buy → Hold |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-12-16 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-06-10 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-12-15 | アップグレード | Goldman | Sell → Neutral |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | アップグレード | Stifel | Hold → Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-05-14 | ダウングレード | DZ Bank | Buy → Hold |
| 2020-03-30 | ダウングレード | Needham | Strong Buy → Buy |
| 2020-03-25 | アップグレード | DZ Bank | Hold → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Sell |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2020-01-02 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-06-05 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 繰り返されました | Needham | Strong Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2019-01-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-12-19 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-08-27 | 繰り返されました | Argus | Buy |
すべてを表示
Medtronic Plc (MDT) 最新ニュース
MDT|Medtronic PLC|Price:83.205|Chg%:+1.195 - TradingKey
MicroPort MedBot To Report First-Ever Profit On Booming Exports - Benzinga
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - GlobeNewswire Inc.
MDT|Medtronic PLC|Price:82.035|Chg%:+0.145 - TradingKey
Medtronic stock trades steadily as recent earnings and diabetes device momentum shape investor view - AD HOC NEWS
Medtronic stock trades steady as diabetes segment grows and guidance holds - Ad-hoc-news.de
Medtronic Earnings Preview: What to Expect - Barchart.com
[Latest] Global Implantable Cardiac Fluorine-Free Resins Market Size/Share Worth USD 4.26 Billion by 2035 at a 10.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate,SWOT Analysis) - GlobeNewswire Inc.
Medtronic PLC (MDT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Medtronic to launch AI compute platform for the operating room - The Robot Report
Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot - Seeking Alpha
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026 - Investing News Network
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Singapore
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
Medtronic adds real-time AI to Hugo robot - MedTech Dive
Medtronic stock trades steady as diabetes and cardiovascular revenue support margins - Ad-hoc-news.de
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026 - BioSpace
Medtronic declares Q2 2026 dividend of R$ 1.33 per unit - Bitget
Medtronic (MDT) to Announce Q1 FY2027 Earnings on August 18 - GuruFocus
Medtronic to announce financial results for its first quarter of fiscal year 2027 - Investing News Network
Medtronic to report Q1 FY2027 financial results on September 1, 2026 - Pluang
Medtronic sets Sept. 1 date for its next financial report - Stock Titan
Medtech acquisitions: DePuy Synthes, Medtronic add to portfolios - Today's Medical Developments
Medtronic stock holds steady as diabetes and cardiovascular growth underpin recent earnings - ad-hoc-news.de
Medtronic acquires SPR Therapeutics for USD 650 million - Medical Buyer
Medtronic : and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - marketscreener.com
Medtronic completes SPR Therapeutics acquisition - MedTech Dive
Medtronic (MDT) Completes SPR Therapeutics Deal To Expand Non Opioid Pain Care - Yahoo Finance
Medtronic stock trades steadily as diabetes and cardiovascular businesses support earnings - ad-hoc-news.de
Medtronic and Apollo Hospitals Announce Strategic Partnership to Establish State-of-the-Art Advanced ICU in Hyderabad - Big News Network.com
Medtronic completes $650M acquisition of SPR Therapeutics - Investing.com UK
Medtronic And Apollo Hospitals Announce Strategic Partnership To Establish State-Of-The-Art Advanced ICU In Hyderabad. - TRIPURA STAR NEWS
Medtronic Completes $650 Million Acquisition of SPR Therapeutics - marketscreener.com
Medtronic completes $650M acquisition of SPR Therapeutics By Investing.com - Investing.com Canada
Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain - Medtronic
Medtronic Adds 60-Day Pain Therapy Without Permanent Implant - Stock Titan
Medtronic (MDT) Completes SPR Therapeutics Acquisition To Expand Non Opioid Pain Care - Sahm
Medtronic plc completed the acquisition of SPR Therapeutics, Inc. - marketscreener.com
Medtronic faces first trial in US hernia mesh injury cases - Reuters
Medtronic PLC (NYSE:MDT): A Top Dividend Stock for Quality and Income Investors - ChartMill
Is Medtronic PLC (MDT) a Bargain After 5.1% Drop? GF Value Says Undervalued - GuruFocus
Medtronic recalls heart valve delivery catheter for risk of tip detaching - MedTech Dive
FDA Flags Medtronic Harmony Catheter Recall As Class I Over Tip Detachment - insights.citeline.com
Baird Adjusts Price Target on Medtronic to $91 From $85, Maintains Neutral Rating - marketscreener.com
BTIG Research Adjusts Medtronic Price Target to $91 From $90, Maintains Buy Rating - marketscreener.com
Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players - Yahoo Finance
Medtronic Plc (MDT) Stock Analysis: A 15.66% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews
Medtronic PLC (XSWX:MDT) Stock Price, Trades & News - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic Plc (MDT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):